OC 42 - Immune-Mediated Thrombocytopenic Disorders

Moderator(s)

• 

  Allyson Pishko, MD (she/her/hers)

  Assistant Professor
  University of Pennsylvania
  Philadelphia, Pennsylvania, United States
• MW

  Margaret Warner, Associate Professor, Department of Medicine, Faculty of Medicine, McGill University

  Hematologist
  McGill University Health Center
  Montreal, Quebec, Canada

Presentations:

• 15:00 – 15:15 ET

  Incidence and Risk Factors of Major Adverse Cardiovascular Events in Patients with Immune-Mediated Thrombotic Thrombocytopenic Purpura During Remission
  

  Presenting Author: Pasquale Agosti, MD, PhD – Università degli Studi di Milano, Department of Pathophysiology and Transplantation and Fondazione Luigi Villa, Milan, Italy

  Co-Author: Federico Boggio – Università degli Studi di Milano

  Co-Author: Pasqualina De Leo – Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico, Angelo Bianchi Bonomi Hemophilia and Thrombosis Center, Milan, Italy

  Co-Author: Addolorata Truma, MD – Università degli Studi di Milano, Department of Pathophysiology and Transplantation

  Co-Author: Juri Alessandro Giannotta, MD – Fondazione IRCCS Ca’ Granda Ospedale Maggiore Policlinico, Angelo Bianchi Bonomi Hemophilia and Thrombosis Center, Milan, Italy

  Co-Author: Andrea Artoni, MD – Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico, Angelo Bianchi Bonomi Hemophilia and Thrombosis Center, Milan, Italy

  Co-Author: Barbara Ferrari – Fondazione IRCCS Ca’ Granda Ospedale Maggiore Policlinico, Angelo Bianchi Bonomi Hemophilia and Thrombosis Center, Milan, Italy

  Co-Author: Ilaria Mancini, PhD – Università degli Studi di Milano, Department of Pathophysiology and Transplantation and Fondazione Luigi Villa, Milan, Italy

  Co-Author: Flora Peyvandi, MD, PhD (she/her/hers) – IRCCS Ca' Granda Maggiore Hospital Foundation, Angelo Bianchi Bonomi Hemophilia and Thrombosis Center, Milano, Italy; Università degli Studi di Milano, Department of Pathophysiology and Transplantation, Milano, Italy
• 15:15 – 15:30 ET

  Immune-mediated TTP patients in remission with recovered ADAMTS13 activity but an open ADAMTS13 conformation are at risk for earlier ADAMTS13 relapse
  

  Co-Author: Laure De Waele – Laboratory for Thrombosis Research, KU Leuven Campus Kulak Kortrijk, Kortrijk

  Presenting Author: Kazuya SAKAI, MD, PhD – Laboratory for Thrombosis Research, KU Leuven Campus Kulak Kortrijk, Kortrijk

  Co-Author: Ilaria Mancini, PhD – Università degli Studi di Milano, Department of Pathophysiology and Transplantation and Fondazione Luigi Villa, Milan, Italy

  Co-Author: György Sinkovits – Department of Internal Medicine and Hematology, Semmelweis University and Research Group for Immunology and Haematology, Semmelweis University - Eötvös Loránd Research Network (Office for Supported Research Groups), Budapest

  Co-Author: Tanja Falter – Institute of Clinical Chemistry and Laboratory Medicine, University Medical Center of the Johannes Gutenberg University Mainz

  Co-Author: Takashi Inoue – Department of Evidence-Based Medicine, Nara Medical University, , Kashihara

  Co-Author: Pasquale Agosti, MD, PhD – Università degli Studi di Milano, Department of Pathophysiology and Transplantation and Fondazione Luigi Villa, Milan, Italy

  Co-Author: Heidi Rossmann – Institute of Clinical Chemistry and Laboratory Medicine, University Medical Center of the Johannes Gutenberg University, Mainz

  Co-Author: Charis Von Auer – Center for Thrombosis and Hemostasis, University Medical Center of the Johannes Gutenberg University, Mainz

  Co-Author: Claudia Tersteeg – Laboratory for Thrombosis Research, KU Leuven Campus Kulak Kortrijk, Kortrijk, Belgium

  Co-Author: Simon F. De Meyer – Laboratory for Thrombosis Research, KU Leuven Campus Kulak Kortrijk, Kortrijk, Belgium

  Co-Author: Bérangère S Joly – Service d’Hématologie Biologique, Hôpital Lariboisière, Assistance Publique–Hôpitaux de Paris and EA3518, Institut de Recherche Saint Louis, Université de Paris, Paris

  Co-Author: Agnès Veyradier – Service d’Hématologie Biologique, Hôpital Lariboisière, Assistance Publique–Hôpitaux de Paris and EA3518, Institut de Recherche Saint Louis, Université de Paris, Paris

  Co-Author: Paul Coppo, MD, PhD (he/him/his) – National Reference Center for Thrombotic Microangiopathy, Hôpital Saint-Antoine, Assistance Publique-Hôpitaux de Paris and Sorbonne – Université (AP-HP.6), Paris, France

  Co-Author: Rob Fijnheer – Department for Clinical Chemistry and Haematology, University Medical Center Utrecht, Utrecht University, Utrecht

  Co-Author: Flora Peyvandi, MD, PhD (she/her/hers) – IRCCS Ca' Granda Maggiore Hospital Foundation, Angelo Bianchi Bonomi Hemophilia and Thrombosis Center, Milano, Italy; Università degli Studi di Milano, Department of Pathophysiology and Transplantation, Milano, Italy

  Co-Author: Zoltan Prohászka – Department of Internal Medicine and Hematology, Semmelweis University and Research Group for Immunology and Haematology, Semmelweis University - Eötvös Loránd Research Network (Office for Supported Research Groups), Budapest

  Co-Author: Bernhard Lämmle – Center for Thrombosis and Hemostasis, University Medical Center of the Johannes Gutenberg University, Mainz

  Co-Author: Karen Vanhoorelbeke, PhD – KU Leuven
• 15:30 – 15:45 ET

  Usefulness of 1E12, a monoclonal anti-Platelet Factor 4 antibody to improve diagnosis of vaccine-induced immune thrombotic thrombocytopenia
  

  Presenting Author: Jérôme Rollin, PhD – University of Tours

  Co-Author: Caroline Vayne – Regional University Hospital Centre Tours

  Co-Author: Rumi Clare – Department of Medicine, Michael G. DeGroote School of Medicine, McMaster University, Hamilton, Ontario, Canada

  Co-Author: Merveille Atsouawe – EA 4245, T2i

  Co-Author: Charlotte Cordonnier – Univ. Lille, Inserm, CHU Lille, U1172

  Co-Author: Sandrine Lemoine – Université d’Angers, Nantes Université, CHU Angers, Inserm, CNRS, CRCI2NA

  Co-Author: Alban Godon – Université d’Angers, Nantes Université, CHU Angers, Inserm, CNRS, CRCI2NA

  Co-Author: Sophie Susen, MD, PhD (she/her/hers) – Univ. Lille, Inserm, CHU Lille, Institut Pasteur de Lille, U1011- EGID, F-59000 Lille, France

  Co-Author: Ishac Nazy, PhD – Department of Medicine, Michael G. DeGroote School of Medicine, McMaster University, Hamilton, Ontario, Canada,

  Co-Author: Yves Gruel – EA 4205, University of Tours, Tours, France

  Co-Author: Claire Pouplard (she/her/hers) – University Hospital of Tours
• 15:45 – 16:00 ET

  Hemorrhagic risk of Caplacizumab in the treatment of Thrombotic thrombocytopenic purpura A pharmacovigilance study from 2020-2022 FAERS Database.
  

  Presenting Author: Niraj Neupane (he/him/his) – Rochester General Hospital

  Co-Author: Sulochana Khadka – Nepalese Army Institute of Health Sciences

  Co-Author: sangharsha Thapa – University of Buffalo

  Co-Author: Soon Khai Low – Rochester General Hospital

  Co-Author: Anil KC – Patan Academy of Health Sciences

  Co-Author: Utsav Joshi – Rochester General Hospital

  Co-Author: Peter Kouides, MD – Mary M. Gooley Hemophilia Centre, Rochester, NY, USA